Loading…
Alpha Cognition Inc. Common Stock is projected to rise to $6.54 by 2027, a +14% move from its current price of $5.73. ACOG is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $5.55 | $5.73 | $5.92 | +0.06% |
| May 30 | $5.48 | $5.74 | $6.01 | +0.12% |
| May 31 | $5.43 | $5.74 | $6.07 | +0.19% |
| Jun 1 | $5.38 | $5.74 | $6.13 | +0.25% |
| Jun 2 | $5.35 | $5.75 | $6.18 | +0.31% |
| Jun 3 | $5.31 | $5.75 | $6.23 | +0.37% |
| Jun 4 | $5.28 | $5.75 | $6.27 | +0.44% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.28 | $5.75 | $6.27 | +0.44% |
| Week 2 | $5.12 | $5.78 | $6.52 | +0.87% |
| Week 3 | $5.00 | $5.81 | $6.73 | +1.31% |
| Week 4 | $4.91 | $5.83 | $6.92 | +1.75% |
| Week 5 | $4.83 | $5.86 | $7.09 | +2.20% |
| Week 6 | $4.77 | $5.88 | $7.26 | +2.64% |
| Week 7 | $4.71 | $5.91 | $7.41 | +3.09% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alpha Cognition Inc. is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases in the United States and Canada. Its commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease, highlighting its role in neurodegenerative disease care.
The company’s pre-clinical development efforts include ZUNVEYL in combination with memantine for moderate-to-severe Alzheimer's disease, ALPHA-1062 sublingual and intranasal formulations, and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs targeting conditions such as amyotrophic lateral sclerosis and spinal muscular atrophy. Alpha Cognition was founded in 2000 and is headquartered in Grapevine, Texas.
Alpha Cognition Inc. Common Stock (ACOG) operates in the Healthcare sector as a biopharmaceutical issuer. The stock’s current price is $5.85, with a market capitalization of $127.38M and a market ranking of 4114.
The near-term forecast for 2026 shows an average price of $5.85 with a 0% ROI and neutral sentiment, within a 30-day range of $4.50 to $7.78. This suggests a flat near-term trajectory around today’s level, with limited downside and modest upside potential in a constrained window.
Longer-term forecasts tilt toward a bullish path, with higher targets emerging in the following years. By 2029 the average target is $7.72, and by 2030 the average target rises to $9.11, with multiple years showing continued bullish sentiment and rising price expectations, culminating in a 2035–2050 horizon where averages reach $13.29 (2035), $22.72 (2040), and $36.39 (2050), accompanied by progressively larger max targets.
A major floor 21.5% below — a decisive break under it would weaken the trend.
The nearest floor, 4.2% below — buyers have tended to step in here.
The nearest ceiling, 22.0% above — a clean break opens room to run.
A major ceiling 32.1% above — clearing it would confirm fresh momentum.
Key ACOG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ACOG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.83 | Sell | $5.81 | Sell |
| MA 10 | $5.84 | Sell | $5.86 | Sell |
| MA 20 | $5.93 | Sell | $5.95 | Sell |
| MA 50 | $6.07 | Sell | $6.02 | Sell |
| MA 100 | $5.89 | Sell | $6.08 | Sell |
| MA 200 | $6.49 | Sell | $6.33 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.11 | Neutral |
| Stoch RSI (14) | 64.13 | Neutral |
| CCI (20) | -86.58 | Neutral |
| Williams %R (14) | -60.66 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -6.07 | Sell |
| Bollinger %B (20,2) | 0.26 | Neutral |
| Stochastic %K (14) | 39.34 | Neutral |
| TRIX (15) | -0.24 | Sell |
| Awesome (5,34) | -0.37 | Sell |
| Ultimate (7,14,28) | 33.15 | Neutral |
| Momentum (10) | 0.24 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 5.83 | Sell |
| ADX (14) | 11.19 | Neutral |
| ATR (14) | 0.17 | Info |
The 30-day technical picture is bearish, with sentiment labeled as BEARISH and RSI14 at 50. The stock trades around key moving averages, with sma50 at $6.07 and sma200 at $6.53, suggesting the price is hovering around short- and medium-term trend indicators.
Near-term support sits at $5.49 and resistance at $6.99, framing a tight range. The 30-day price range spans from $4.68 to $7.32, indicating modest volatility over the period. Annualized volatility is reported at 60%, underscoring notable price variability within a month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.50 | $5.73 | $7.57 | 0% | Neutral | |
| $5.09 | $6.54 | $8.95 | +14% | Neutral | |
| $4.94 | $6.56 | $9.35 | +14% | Neutral | |
| $5.57 | $7.59 | $11.19 | +33% | Bullish | |
| $6.41 | $8.96 | $13.56 | +56% | Bullish | |
| $7.34 | $10.50 | $16.28 | +83% | Bullish | |
| $8.44 | $12.33 | $19.53 | +115% | Bullish | |
| $8.40 | $12.52 | $20.22 | +119% | Bullish | |
| $8.20 | $12.46 | $20.48 | +117% | Bullish | |
| $8.43 | $13.04 | $21.80 | +128% | Bullish | |
| $13.33 | $22.44 | $40.19 | +292% | Bullish | |
| $18.46 | $36.06 | $71.35 | +529% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.50 | $5.73 | $6.79 | +0.00% |
| June 2026 | $5.14 | $6.07 | $7.34 | +5.85% |
| July 2026 | $5.09 | $6.06 | $7.46 | -0.02% |
| August 2026 | $5.02 | $6.03 | $7.51 | -0.55% |
| September 2026 | $5.14 | $6.21 | $7.80 | +2.97% |
| October 2026 | $5.11 | $6.21 | $7.87 | -0.02% |
| November 2026 | $4.86 | $5.94 | $7.59 | -4.35% |
| December 2026 | $4.79 | $5.88 | $7.57 | -1.00% |
Click any year to see its month-by-month ACOG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ACOG to range from $4.50 to $7.57 through 2026. The $5.73 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The ACOG price prediction for 2027 points to an average of $6.54 (low $5.09, high $8.95) — a potential gain of +14% on today's $5.73. Price action looks broadly range-bound.
In 2028, ACOG is projected to trade between $4.94 and $9.35, averaging $6.56 — a potential gain of +14% from today's $5.73. That is up 0% on the projected 2027 average. A consolidation phase looks the most probable path here.
Alpha Cognition Inc. Common Stock's 2029 outlook centres on $7.59, within a $5.57 to $11.19 range. That is up +16% on the projected 2028 average. That marks a +33% change versus current levels. Momentum favours further upside here.
By 2030, ACOG could reach as high as $13.56, with a base case around $8.96 and support toward $6.41 — roughly +56% from $5.73. Buyers look set to stay in control over this stretch.
Expect ACOG to range from $7.34 to $16.28 through 2031. The $10.50 average target implies a +83% move from current prices. That is up +17% on the projected 2030 average. Momentum favours further upside here.
The ACOG price prediction for 2032 points to an average of $12.33 (low $8.44, high $19.53) — a potential gain of +115% on today's $5.73. Buyers look set to stay in control over this stretch.
In 2033, ACOG is projected to trade between $8.40 and $20.22, averaging $12.52 — a potential gain of +119% from today's $5.73. That is up +2% on the projected 2032 average. Momentum favours further upside here.
Alpha Cognition Inc. Common Stock's 2034 outlook centres on $12.46, within a $8.20 to $20.48 range. That is 0% versus the projected 2033 average. That marks a +117% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, ACOG could reach as high as $21.80, with a base case around $13.04 and support toward $8.43 — roughly +128% from $5.73. Momentum favours further upside here.
Expect ACOG to range from $13.33 to $40.19 through 2040. The $22.44 average target implies a +292% move from current prices. That is up +72% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The ACOG price prediction for 2050 points to an average of $36.06 (low $18.46, high $71.35) — a potential gain of +529% on today's $5.73. Momentum favours further upside here.
Investing $1,000 in ACOG today (≈ 174.52007 ACOG) could be worth
$6,293.13
+$5,293.13 (+529%) by 2050 · US Dollar
Based on the average projected ACOG price of $36.06 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ACOGwould be worth at today's price.
$1,000 invested in ACOG on May 27, 2025 (≈ 113.378689 ACOG) would be worth
$649.66
-$350.34 (-35.0%) today · 0.65× · US Dollar
Based on a ACOG entry price of $8.82 vs. today's $5.73.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.89 | $972.84 | -2.7% |
| 1 month ago | $6.43 | $891.14 | -10.9% |
| 3 months ago | $6 | $955 | -4.5% |
| 6 months ago | $6.02 | $951.83 | -4.8% |
| 1 year ago | $8.82 | $649.66 | -35.0% |
| All time (1.5y) ago | $5.7 | $1,005.26 | +0.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ACOG forecast.
Our base-case forecast reaches $11.00 around 2032.
Implied market cap at $11.00: $239.52M
The multi-year forecast shows a clear bullish trajectory after the near-term window. By 2027 the average target is $6.67 with a bullish/neutral mix, rising further in 2028 to $6.60 and in 2029 to $7.72, with a bullish sentiment. The 2030 target climbs to an average of $9.11 and a max of $13.95, supported by a 55.7% ROI in that year.
Looking further out, 2040 projects an average of $22.72 and a max of $41.39 with a 288.3% ROI, and 2050 shows an average of $36.39 and a max of $73.48 with a 522% ROI, both labeled bullish. These figures illustrate a long-run upside potential, though they remain estimates and are not guaranteed. Investors should consider the associated uncertainty and market conditions when evaluating such forecasts.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $6.44, an average of $9.11, and a max of $13.95, with an ROI of 55.7% and bullish sentiment.
Forecasts indicate rising averages after 2026, with a 2030 average of $9.11 and long-run bullish targets (2040 average $22.72; 2050 average $36.39) and ROI up to 522%, though these are estimates and not guarantees.
According to the forecast, the 2050 max is $73.48, which would exceed $50, while the 2040 max is $41.39 (below $50). The 2030–2035 window shows more modest upside.
Bearish sentiment with RSI14 at 50. The sma50 is $6.07 and the sma200 is $6.53. Immediate support is $5.49 and resistance is $6.99, with a 30-day price range of $4.68 to $7.32 and volatility at 60%.
Current price is $5.85 and market cap is $127.38M, with a market rank of 4114.
Alpha Cognition Inc. Common Stock Community Discussion
0Share your Alpha Cognition Inc. Common Stock price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.